MedTrace Logo

Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer

NCT06572540 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-07-18

No results posted yet for this study

Summary

The study aims to compare the efficacy and safety of transthoracic cryoablation to transbronchial cryoablation in the treatment of early-stage peripheral lung cancer.

Conditions

Interventions

DEVICE

Transthoracic cryoablation

Transthoracic cryoablation will be performed under the guidance of CT.

DEVICE

Transbronchial cryoablation

Transbronchial cryoablation will be performed under the guidance of navigation bronchoscopy and CBCT.

Sponsors & Collaborators

  • Jiayuan Sun

    lead OTHER

Principal Investigators

  • Jiayuan Sun, PhD · Shanghai Chest Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06572540 on ClinicalTrials.gov